Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Sebben Paes

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisGabriela Mantovani Baldasso, Christian Limberger, Rodrigo Sebben Paes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRodrigo Sebben Paes, Gabriela Mantovani Baldasso, Christian Limberger, et al.
Pharmacological Research|April 24, 2026
Corrigendum to "The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives" [Pharmacol. Res. 227 (2026) 108185]Gabriela Mantovani Baldasso, Rodrigo Sebben Paes, Artur Graeff Moreira, et al.
Pharmacological Research|April 5, 2026
The role of cannabinoid ligands in neurodegenerative diseases: emerging anti-inflammatory, immunomodulation and disease-modifying perspectivesGabriela Mantovani Baldasso, Rodrigo Sebben Paes, Artur Graeff Moreira, et al.
Neural Regeneration Research|July 16, 2021
Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in miceCarlos Pereira Martins, Rodrigo Sebben Paes, Gabriela Mantovani Baldasso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRoberta Dos Santos de Oliveira, Christian Limberger, Gabriel Colissi Martins, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2022
Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in miceEduarda Gomes Ferrarini, Rodrigo Sebben Paes, Gabriela Mantovani Baldasso, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisGabriela Mantovani Baldasso, Christian Limberger, Rodrigo Sebben Paes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRodrigo Sebben Paes, Gabriela Mantovani Baldasso, Christian Limberger, et al.
Pharmacological Research|April 24, 2026
Corrigendum to "The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives" [Pharmacol. Res. 227 (2026) 108185]Gabriela Mantovani Baldasso, Rodrigo Sebben Paes, Artur Graeff Moreira, et al.
Pharmacological Research|April 5, 2026
The role of cannabinoid ligands in neurodegenerative diseases: emerging anti-inflammatory, immunomodulation and disease-modifying perspectivesGabriela Mantovani Baldasso, Rodrigo Sebben Paes, Artur Graeff Moreira, et al.
Neural Regeneration Research|July 16, 2021
Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in miceCarlos Pereira Martins, Rodrigo Sebben Paes, Gabriela Mantovani Baldasso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRoberta Dos Santos de Oliveira, Christian Limberger, Gabriel Colissi Martins, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2022
Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in miceEduarda Gomes Ferrarini, Rodrigo Sebben Paes, Gabriela Mantovani Baldasso, et al.
Pageof 1